Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

RTA 408 cream protects mice from radiation skin damage.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Concentrated nanofat helps mice grow hair by activating skin cells and may be used to treat hair loss.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.